Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS

v3.22.4
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS
 
Our joint venture in China, owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, borrowed $0 from the Company during the years ended December 31, 2022 and 2021. At December 31, 2022 and 2021 our joint venture in China held a note payable to the Company of $0 and $1.2 million, respectively. Our joint venture in China borrowed $0 from our joint venture partner, during the years ended December 31, 2022 and 2021. At December 31, 2022 and 2021, our joint venture in China held a note payable to our joint venture partner of $0 and $0.3 million, respectively. These
notes are payable in one year and bear interest of 3.0 percent. The note between the joint venture and the Company eliminates in consolidation.